FLT3LG

gene product
Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts (summary by Sathaliyawala et al., 2010 [PubMed 20933441]). [supplied by OMIM, Jan 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
371 antibodies from 30 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
26 antibodies
R&D Systems
9 antibodies
antibodies-online
110 antibodies
GeneTex
7 antibodies
Affinity Biosciences
1 antibody
Abnova Corporation
7 antibodies
LifeSpan BioSciences, Inc.
82 antibodies
OriGene
8 antibodies
Bioworld Technology, Inc
1 antibody
Biorbyt
24 antibodies
RabMAbs
2 antibodies
Abgent
2 antibodies
NSJ Bioreagents
4 antibodies
Aviva Systems Biology
4 antibodies
Abbkine Scientific Co.Ltd.
2 antibodies
Acris Antibodies GmbH
12 antibodies
Creative Biolabs
16 antibodies
Abiocode, Inc.
3 antibodies
Boster Biological Technology
2 antibodies
Creative Diagnostics
6 antibodies
Invitrogen Antibodies
3 antibodies
St John's Laboratory
2 antibodies
GenWay
2 antibodies
United States Biological
19 antibodies
MyBioSource
6 antibodies
Sigma-Aldrich
3 antibodies
PeproTech Inc.
2 antibodies
Abbexa
3 antibodies
ProSci
2 antibodies
RayBiotech, Inc.
1 antibody